MedTrace Logo

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

NCT06555315 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-08-15

No results posted yet for this study

Summary

Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates

Conditions

  • Very Low Birth Weight Infant
  • Premature Infants
  • Anemia of Prematurity
  • Iron Deficiency, Anaemia in Children
  • Extremely Low Birth Weight

Interventions

DIETARY_SUPPLEMENT

6 mg/kg of oral iron as ferrous sulfate administered every other day.

6mg/kg of oral iron as ferrous sulfate administered every other day instead of 6 mg/kg of oral iron daily supplementation.

DIETARY_SUPPLEMENT

6 mg/kg of oral iron as ferrous sulfate administered every day.

6 mg/kg of oral iron as daily ferrous sulfate instead of 6mg/kg of oral iron supplementation administered every other day.

Sponsors & Collaborators

  • CHRISTUS Health

    lead OTHER

Principal Investigators

  • Pratik K Parikh, MD · CHRISTUS Health

  • Richelle L Homo, MD · CHRISTUS Health; Brooke Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
26 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-03-28
Completion
2026-03-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555315 on ClinicalTrials.gov